US Bancorp
TECX

US Bancorp’s Tectonic Therapeutic TECX Stock Holding History

US Bancorp’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.1K Sell
1,080
-56
-5% -$1.65K ﹤0.01% 2941
2026
Q1 		$35.1K Buy
1,136
+1,099
+2,970% +$27K ﹤0.01% 2857
2025
Q4 		$772 Hold
37
– – ﹤0.01% 3888
2025
Q3 		$581 Hold
37
– – ﹤0.01% 3861
2025
Q2 		$735 Sell
37
-8
-18% -$162 ﹤0.01% 3977
2025
Q1 		$797 Sell
45
-24
-35% -$782 ﹤0.01% 4008
2024
Q4 		$3.19K Buy
69
+37
+116% +$1.56K ﹤0.01% 3756
2024
Q3 		$970 Buy
+32
New +$585 ﹤0.01% 3896
2021
Q3 		– Sell
-16
Closed -$2K – 4190
2021
Q2 		$2K Hold
16
– – ﹤0.01% 3856
2021
Q1 		$2K Hold
16
– – ﹤0.01% 3738
2020
Q4 		$3K Hold
16
– – ﹤0.01% 3529
2020
Q3 		$2K Hold
16
– – ﹤0.01% 3532
2020
Q2 		$3K Buy
+16
New +$3.3K ﹤0.01% 3456
2020
Q1 		– Sell
-17
Closed -$4K – 3815
2019
Q4 		$4K Sell
17
-3
-15% -$578 ﹤0.01% 3358
2019
Q3 		$3K Buy
+20
New +$4.53K ﹤0.01% 3366

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

US Bancorp's TECX Position: Q2 2026 in Review

US Bancorp reduced its Tectonic Therapeutic (TECX) stake by 4.9% in Q2 2026, selling an estimated $1.65K and leaving 1,080 shares worth $37.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

US Bancorp first reported a position in TECX in Q3 2019 and has held it in 15 quarters since. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • US Bancorp held 1,080 shares of Tectonic Therapeutic worth $37.1K as of Q2 2026.
  • US Bancorp sold 56 Tectonic Therapeutic shares in Q2 2026, an estimated $1.65K.
  • Tectonic Therapeutic made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2941 holding.
  • US Bancorp first reported a position in Tectonic Therapeutic in Q3 2019 and has held it in 15 quarters since.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.